Back

Patient self-adjustment of diuretics in heart failure: evidence gaps despite guideline recommendations - insights from a scoping review

9 May 2026 (10:30 - 11:00)
Organised by: Logo
Congress Presentation Part of: Optimisation strategies in heart failure treatment Pharmacotherapy HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Ms Ethel O'Donoghue

St Vincent's University Hospital, Dublin (Ireland)

3 More presentations in this session

Presentation thumbnail
Healthcare utilisation and clinical outcomes following implementation of an accelerated treatment pathway for patients with HFrEF.
Mrs M. Copley (Auckland, NZ)
Abstract Slides Video
Presentation thumbnail
The prognostic role of regular NT-proBNP measurement after a rapid-up titration programme of guideline-directed medical therapy in heart failure: essential or superfluous?
Doctor B. Muk (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
The effect of increase in NT-proBNP on the efficacy and safety of a rapid up-titration of guideline-directed medical therapy in patients with low predischarge NT-proBNP
Doctor J. Papp (Budapest, HU)
Abstract Slides Video

Access the full session

Session thumbnail
Optimisation strategies in heart failure treatment

The Event

Event poster

Heart Failure 2026

9 May 2026 10:30 CET
You may be interested in
thumbnail
Congress Presentation
Discussant review - DEA-HF
thumbnail
Congress Presentation
Diuretic discontinuation after heart failure hospitalisation
thumbnail
Congress Presentation
Community-based intravenous diuretic therapy delivered through a collaborative heart failure and community paramedic model: a real-world service evaluation

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources